Pepito, Reynaldo P.
HRN: 18-20-77 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/02/2025
04/09/2025
IV
1.5g
Q12
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes